These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26703840)

  • 21. In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.
    Tan H; Wei K; Bao J; Zhou X
    Mol Biosyst; 2013 Nov; 9(11):2764-74. PubMed ID: 24056678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.
    Schaduangrat N; Phanich J; Rungrotmongkol T; Lerdsamran H; Puthavathana P; Ubol S
    J Gen Virol; 2016 Jun; 97(6):1311-1323. PubMed ID: 26935590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK; Basu S; Cherian SS
    Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ; Du QS; Chou KC
    Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.
    Li Q; Qi J; Wu Y; Kiyota H; Tanaka K; Suhara Y; Ohrui H; Suzuki Y; Vavricka CJ; Gao GF
    J Virol; 2013 Sep; 87(18):10016-24. PubMed ID: 23824808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ; Hall RJ
    J Mol Recognit; 2015 Sep; 28(9):521-7. PubMed ID: 25727669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic residue interaction network analysis of the oseltamivir binding site of N1 neuraminidase and its H274Y mutation site conferring drug resistance in influenza A virus.
    Yadav M; Igarashi M; Yamamoto N
    PeerJ; 2021; 9():e11552. PubMed ID: 34141489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation.
    Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
    Biochemistry; 2013 Nov; 52(45):8150-64. PubMed ID: 24128064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y; Baz M; Boivin G
    Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
    Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
    Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug susceptibility of wild-type and mutant H7N9 neuraminidase to zanamivir and oseltamivir].
    Wei YN; Zhang C; Chen Q; Guo Y
    Bing Du Xue Bao; 2014 Jul; 30(4):396-401. PubMed ID: 25272593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsecond dynamics of H10N7 influenza neuraminidase reveals the plasticity of loop regions and drug resistance due to the R292K mutation.
    Sk MF; Samanta S; Poddar S; Kar P
    J Comput Chem; 2024 Feb; 45(5):247-263. PubMed ID: 37787086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
    García-Sosa AT; Sild S; Maran U
    J Chem Inf Model; 2008 Oct; 48(10):2074-80. PubMed ID: 18847186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a surface plasmon resonance assay to measure the binding affinity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drug zanamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ
    J Mol Recognit; 2015 Feb; 28(2):87-95. PubMed ID: 25599664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Protoplasma; 2013 Feb; 250(1):197-207. PubMed ID: 22392098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.